JP2010162016A5 - - Google Patents

Download PDF

Info

Publication number
JP2010162016A5
JP2010162016A5 JP2009256885A JP2009256885A JP2010162016A5 JP 2010162016 A5 JP2010162016 A5 JP 2010162016A5 JP 2009256885 A JP2009256885 A JP 2009256885A JP 2009256885 A JP2009256885 A JP 2009256885A JP 2010162016 A5 JP2010162016 A5 JP 2010162016A5
Authority
JP
Japan
Prior art keywords
polypeptide
antibody
seq
cell
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009256885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010162016A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010162016A publication Critical patent/JP2010162016A/ja
Publication of JP2010162016A5 publication Critical patent/JP2010162016A5/ja
Pending legal-status Critical Current

Links

JP2009256885A 2002-09-25 2009-11-10 乾癬の治療のための新規組成物と方法 Pending JP2010162016A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41400602P 2002-09-25 2002-09-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004540290A Division JP2006513700A (ja) 2002-09-25 2003-09-25 乾癬の治療のための新規組成物と方法

Publications (2)

Publication Number Publication Date
JP2010162016A JP2010162016A (ja) 2010-07-29
JP2010162016A5 true JP2010162016A5 (enExample) 2011-02-10

Family

ID=32043325

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004540290A Pending JP2006513700A (ja) 2002-09-25 2003-09-25 乾癬の治療のための新規組成物と方法
JP2009256885A Pending JP2010162016A (ja) 2002-09-25 2009-11-10 乾癬の治療のための新規組成物と方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004540290A Pending JP2006513700A (ja) 2002-09-25 2003-09-25 乾癬の治療のための新規組成物と方法

Country Status (6)

Country Link
US (3) US20070042945A1 (enExample)
EP (2) EP1585482A4 (enExample)
JP (2) JP2006513700A (enExample)
AU (2) AU2003279084A1 (enExample)
CA (1) CA2499843A1 (enExample)
WO (1) WO2004028479A2 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638284B2 (en) * 2000-10-31 2009-12-29 The Curators Of The University Of Missouri Immunoglobulin A inducing protein and uses therefor
US7449548B2 (en) * 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
US7803906B2 (en) * 2002-03-22 2010-09-28 Gene Signal International Sa Composition comprising an angiogenesis related protein
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
JP2006513700A (ja) * 2002-09-25 2006-04-27 ジェネンテック・インコーポレーテッド 乾癬の治療のための新規組成物と方法
EP2298874A1 (en) 2002-12-16 2011-03-23 Halozyme, Inc. Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
CA2518101A1 (en) * 2003-03-03 2005-06-09 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
EP1601693A2 (en) * 2003-03-11 2005-12-07 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
DE602004029058D1 (de) 2003-07-09 2010-10-21 Shinonogi & Co Ltd Inducer von atopischer dermatitis
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7723497B2 (en) * 2003-12-11 2010-05-25 Washington University In St. Louis Human IPLA2ε
US7473541B2 (en) * 2004-07-09 2009-01-06 Gross Richard W Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7960100B1 (en) 2004-04-30 2011-06-14 Celera Corporation Colon cancer targets and uses thereof
WO2005111213A1 (ja) * 2004-05-18 2005-11-24 Kurume University Ｍｙｃ標的遺伝子mimitin
GB0414325D0 (en) * 2004-06-25 2004-07-28 Celltech R&D Ltd A protein involved in cancer
JP2008506949A (ja) * 2004-07-13 2008-03-06 メタボレックス インコーポレーティッド 肥満、糖尿病およびインスリン抵抗性の診断および治療の方法
WO2006063462A1 (en) 2004-12-13 2006-06-22 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
EP1851543A2 (en) 2005-02-24 2007-11-07 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
US20100040636A1 (en) * 2005-09-09 2010-02-18 The Johns Hopkins University Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists
US8044179B2 (en) 2005-09-13 2011-10-25 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
JP5269597B2 (ja) * 2005-09-27 2013-08-21 ナショナル リサーチ カウンシル オブ カナダ 血液―脳隔壁エピトープとその利用
DE102005059242A1 (de) * 2005-12-12 2007-06-14 Johannes Gutenberg-Universität Mainz, Vertreten Durch Den Präsidenten Molekulare Marker für eine Tumordiagnose und -therapie
WO2007076523A2 (en) * 2005-12-28 2007-07-05 Centocor, Inc. Markers and methods for assessing and treating psoriasis and related disorders
CA2644162A1 (en) * 2006-03-07 2007-09-13 Telethon Institute For Child Health Research Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same
FR2908784B1 (fr) 2006-11-17 2012-12-14 Oreal Utilisation cosmetique d'une proteine de la famille des ribonucleases
FR2908654B1 (fr) 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
US20120030779A1 (en) * 2007-01-18 2012-02-02 University Of Utah Research Foundtion Compositions and methods for detecting, treating, or preventing reductive stress
CA2685551C (en) 2007-05-16 2016-11-29 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
CA2702655A1 (en) * 2007-10-19 2009-04-23 Rappaport Family Institute For Research In The Medical Sciences Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
US9808506B2 (en) 2007-10-19 2017-11-07 Rappaport Family Institute For Research In The Medical Sciences Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof
US8168586B1 (en) 2007-11-21 2012-05-01 Celera Corporation Cancer targets and uses thereof
FR2925314B1 (fr) * 2007-12-19 2012-11-23 Oreal Utilisation cosmetique de proteines de type transglutaminase 3
DE102008033381B4 (de) * 2008-07-07 2013-12-24 Alexander Steinle Modulation der Immunantwort durch den Rezeptor NKp65 und seine Liganden
EP2504363B1 (en) 2009-11-24 2019-05-08 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
WO2011106839A1 (en) * 2010-03-03 2011-09-09 Children's Cancer Institute Australia for Medical Research Skin cancer prevention and treatment
AU2013224591A1 (en) 2012-02-22 2014-07-24 Alethia Biotherapeutics Inc. Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer
MX360236B (es) 2012-06-27 2018-10-26 Berg Llc Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide
US10201610B2 (en) * 2014-10-20 2019-02-12 The University Of Western Australia Interference peptides and use thereof
SG10202012249YA (en) 2014-12-08 2021-01-28 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
KR20170132202A (ko) * 2015-03-20 2017-12-01 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Isg15 및 어쥬번트로써의 이의 용도
SG11202106100VA (en) 2018-12-21 2021-07-29 23Andme Inc Anti-il-36 antibodies and methods of use thereof
KR102065171B1 (ko) * 2019-02-20 2020-01-13 (주)케어젠 대기오염물질에 의한 피부 손상 방지 및 항노화용 펩타이드와 이의 용도
CN112175949B (zh) * 2020-09-23 2021-05-04 山东大学第二医院 lncRNA RP11-394O4.6在抑制膀胱癌细胞生物学功能中的应用
WO2024246046A1 (en) 2023-05-31 2024-12-05 Corequest Sagl Gene delivery to cells of vectors comprising crat nucleotidic or aminoacidic sequences

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4943529A (en) 1982-05-19 1990-07-24 Gist-Brocades Nv Kluyveromyces as a host strain
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
AU3145184A (en) 1983-08-16 1985-02-21 Zymogenetics Inc. High expression of foreign genes in schizosaccharomyces pombe
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
JPS63502716A (ja) 1986-03-07 1988-10-13 マサチューセッツ・インステチュート・オブ・テクノロジー 糖タンパク安定性の強化方法
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4946783A (en) 1987-01-30 1990-08-07 President And Fellows Of Harvard College Periplasmic protease mutants of Escherichia coli
US5223425A (en) * 1987-04-02 1993-06-29 The Beth Israel Hospital Association DNA encoding human adipsin with complement D activity
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5169770A (en) 1987-12-21 1992-12-08 The University Of Toledo Agrobacterium mediated transformation of germinating plant seeds
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
ES2038579T3 (es) 1989-04-28 1997-02-16 Rhein Biotech Proz & Prod Gmbh Celulas de levadura del genero schwanniomyces.
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
DE69029036T2 (de) 1989-06-29 1997-05-22 Medarex Inc Bispezifische reagenzien für die aids-therapie
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
KR0149181B1 (ko) 1990-06-29 1998-08-17 데이비드 알, 맥지 형질전환된 미생물에 의한 멜라닌의 제조방법
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
DE69133476T2 (de) 1990-08-29 2006-01-05 GenPharm International, Inc., Palo Alto Transgene Mäuse fähig zur Produktion heterologer Antikörper
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP0617706B1 (en) 1991-11-25 2001-10-17 Enzon, Inc. Multivalent antigen-binding proteins
WO1994011026A2 (en) 1992-11-13 1994-05-26 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
EP0616812B1 (en) 1993-03-24 1999-11-03 Berlex Biosciences Combination with anti-hormonal compounds and binding molecules for the treatment of cancer
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6458939B1 (en) 1996-03-15 2002-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
US5863769A (en) * 1997-01-28 1999-01-26 Smithkline Beecham Corporation DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
JPH10221340A (ja) * 1997-02-07 1998-08-21 Advanced Sukin Res Kenkyusho:Kk 皮膚疾患の診断方法および薬効評価方法
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2317689T3 (es) * 1998-02-20 2009-04-16 Genentech, Inc. Inhibidores de la activacion del complemento.
WO2000008045A2 (en) * 1998-08-07 2000-02-17 Millennium Pharmaceuticals, Inc. Novel molecules of the tango-93-related protein family and uses thereof
AU6296899A (en) * 1998-10-08 2000-04-26 Zymogenetics Inc. Interleukin-1 homolog
CA2354027A1 (en) * 1998-12-23 2000-07-06 Genentech, Inc. Il-1 related polypeptides
US20020076762A1 (en) * 1999-05-14 2002-06-20 Incyte Pharmaceuticals, Inc. Full-length expressed genetic markers
FR2797402B1 (fr) * 1999-07-15 2004-03-12 Biomerieux Stelhys Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
JP2003523943A (ja) * 1999-07-16 2003-08-12 インターリューキン ジェネティックス インコーポレイテッド Ｉｌ−１ｌ１遺伝子およびポリペプチド生成物
EP1250426A2 (en) * 1999-12-01 2002-10-23 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding same
EP1358348A2 (en) * 2000-05-09 2003-11-05 Genetics Institute, LLC Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
US7329729B1 (en) * 2000-06-21 2008-02-12 Amgen Inc. Secreted epithelial colon stromal-1 molecules and uses thereof
JP2004516013A (ja) * 2000-07-20 2004-06-03 ジェネンテック・インコーポレーテッド 血管形成に関連する障害を診断及び治療するための組成物と方法
JP2006513700A (ja) * 2002-09-25 2006-04-27 ジェネンテック・インコーポレーテッド 乾癬の治療のための新規組成物と方法

Similar Documents

Publication Publication Date Title
JP2010162016A5 (enExample)
CA2771441C (en) Antibodies for the detection of integrin complexes in ffpe material
JP2005046146A5 (enExample)
CA2479494A1 (en) Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor
JP2006516094A5 (enExample)
JP2008301822A5 (enExample)
JP2006223304A5 (enExample)
CA2503125A1 (en) Novel composition and methods for the treatment of immune related diseases
US20090280507A1 (en) Method for measurement of sars virus nucleocapsid protein, reagent kit for the measurement, test device, monoclonal antibody directed against sars virus nucleocapsid protein, and hybridoma capable of producing the monoclonal antibody
WO2008103849A4 (en) Methods and compounds for lymphoma cell detection and isolation
HK1221490A1 (zh) 以生物樣品進行的針對igfbp7的具有改進的性能的測定
AU2011261308A1 (en) Markers for renal disease
RU2013142334A (ru) КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ ДЛЯ ОПРЕДЕЛЕНИЯ НЕ4а
JP2006518582A5 (enExample)
RU2018138782A (ru) Антитела к фактору ix padua
JP2006521810A5 (enExample)
JP2006521082A5 (enExample)
JP2005518212A5 (enExample)
JP5580967B2 (ja) ブタ繁殖性呼吸器症候群ウイルスに対する抗体を検出するためのペプチド
JP2005502344A5 (enExample)
EP4293360A1 (en) Adult still's disease inspection method and inspection kit
JP2003527844A5 (enExample)
JP2010029191A5 (enExample)
JP2006519582A5 (enExample)
JP2006502738A5 (enExample)